Cancer immunoediting from immune surveillance to immune escape

Ehrlich P, 1909, Ueber den jetzigen stand der karzinomforschung, Ned Tijdschr Geneeskd, 5, 73

10.1136/bmj.1.5023.841

10.1038/ni1102-991

10.1038/ni1213

10.1158/0008-5472.CAN-05-4128

Klein G, 1976, Immune surveillance – a powerful mechanism with a limited range, Natl Cancer Inst Monogr, 44, 109

Prehn RT, 1957, Immunity to methylcholanthrene‐induced sarcomas, J Natl Cancer Inst, 18, 769

10.1146/annurev.me.15.020164.001123

Burnet FM, 1971, Immunological surveillance in neoplasia, Transplant Rev, 7, 3

Thomas L, 1982, On immunosurveillance in human cancer, Yale J Biol Med, 55, 329

Rygaard J, 1974, The mouse mutant nude does not develop spontaneous tumours. An argument against immunological surveillance, Acta Pathol Microbiol Scand Microbiol Immunol, 82, 99

10.1126/science.183.4124.534

10.1073/pnas.81.3.886

Maleckar JR, 1987, The composition of the T cell receptor repertoire in nude mice, J Immunol, 138, 3873, 10.4049/jimmunol.138.11.3873

10.1111/j.1699-0463.1996.tb04923.x

10.1046/j.1365-3083.1997.d01-419.x

10.1016/S0065-230X(08)60936-7

10.1084/jem.191.4.661

10.1093/intimm/13.4.459

10.1073/pnas.1630663100

10.1126/science.1063916

10.1016/1074-7613(94)90087-6

10.1073/pnas.95.13.7556

10.1182/blood.V97.1.192

10.1084/jem.20020063

10.1146/annurev.immunol.20.100201.131730

10.1084/jem.184.5.1781

10.1084/jem.192.5.755

10.1016/0092-8674(92)90029-C

10.1038/35074122

10.1093/jnci/52.2.553

Affabris E, 1987, Molecular mechanisms of action of interferons in the Friend virus‐induced leukemia cell system, Haematologica, 72, 76

10.1084/jem.168.4.1271

10.1016/S1074-7613(00)80218-6

10.1084/jem.20051395

10.1093/intimm/dxf089

10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B

10.4049/jimmunol.164.2.567

10.1016/S1074-7613(00)80564-6

Naito Y, 1998, CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer, Cancer Res, 58, 3491

10.1136/gut.2004.052696

10.1016/S0003-4975(00)01915-9

Reichert TE, 1998, Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma, Cancer Res, 58, 5344

10.1002/1097-0142(19931115)72:10<2993::AID-CNCR2820721022>3.0.CO;2-6

10.1073/pnas.0509182102

10.1007/s00262-005-0018-5

10.1002/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V

10.1159/000072714

10.1016/S0169-5002(01)00292-6

10.1002/ijc.2910600209

10.1016/0003-4975(95)00120-4

10.1097/01.ASN.0000126194.77004.9B

10.1097/00007890-200208150-00011

10.1053/ajkd.2002.29926

10.1016/j.dnarep.2004.03.027

10.1016/j.bbrc.2005.03.190

10.4161/cc.4.7.1800

10.1038/356215a0

10.1016/j.imlet.2005.06.024

10.1007/s00262-006-0164-4

10.1007/s002620050384

10.1038/83416

10.1007/3-540-27743-9_8

10.1146/annurev.iy.12.040194.005015

10.1038/86297

10.1038/35095564

10.1084/jem.20031981

10.1158/0008-5472.CAN-05-1387

Qin Z, 2003, A critical requirement of interferon gamma‐mediated angiostasis for tumor rejection by CD8+ T cells, Cancer Res, 63, 4095

Wall L, 2003, IFN‐gamma induces apoptosis in ovarian cancer cells in vivo and in vitro, Clin Cancer Res, 9, 2487

10.1084/jem.182.1.155

10.1016/S1359-6101(01)00038-7

10.1007/s00262-005-0703-4

10.1038/nature01991

10.1111/j.1462-5822.2007.00914.x

10.1007/s000180300035

10.1385/IR:31:3:207

10.1038/nature04870

10.4161/cbt.4.9.2101

10.1002/eji.1830260827

10.1146/annurev.immunol.22.012703.104803

10.1056/NEJM200302063480620

Cankovic M, 2006, Use of microsatellite analysis in detection of tumor lineage as a cause of death in a liver transplant patient, Arch Pathol Laboratory Med, 130, 529, 10.5858/2006-130-529-UOMAID

10.1097/01.tp.0000168489.71242.fd

10.1002/lt.20457

Von Bernstorff W, 2001, Systemic and local immunosuppression in pancreatic cancer patients, Clin Cancer Res, 7, 925s

Schmielau J, 2001, Suppressed T‐cell receptor zeta chain expression and cytokine production in pancreatic cancer patients, Clin Cancer Res, 7, 933s

Staibano S, 2006, Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior?, Int J Immunopathol Pharmacol, 19, 171, 10.1177/205873920601900117

10.1081/CNV-200039653

10.1067/msy.2001.114554

10.1172/JCI3784

Gastman BR, 1999, Caspase‐mediated degradation of T‐cell receptor zeta‐chain, Cancer Res, 59, 1422

10.1182/blood.V95.6.2015

10.1158/1078-0432.1010.11.3

10.1182/blood.V92.11.4150

10.1016/S1044-579X(03)00024-5

10.1002/1097-0029(20010215)52:4<387::AID-JEMT1023>3.0.CO;2-W

He X, 1999, Prostaglandin E2 selectively inhibits human CD4+ T cells secreting low amounts of both IL‐2 and IL‐4, J Immunol, 163, 6173, 10.4049/jimmunol.163.11.6173

Erdogan B, 2005, The evaluation of soluble Fas and soluble Fas ligand levels of bronchoalveolar lavage fluid in lung cancer patients, Tuberk Toraks, 53, 127

10.1002/cncr.20270

10.1007/s00262-006-0167-1

10.1182/blood.V97.5.1427

10.1126/science.1073514

10.1158/0008-5472.CAN-05-0045

10.4049/jimmunol.160.3.1224

10.1038/sj.onc.1208719

10.1038/nm976

10.1038/nm1325

10.1016/S0169-5002(01)00285-9

10.1002/cncr.11399

10.1016/S0025-5564(02)00120-7

10.4049/jimmunol.171.12.6891

10.1053/j.gastro.2005.03.045

10.1054/bjoc.2001.2042

10.1038/nature01112

10.1038/nm1100

10.1007/s00262-004-0577-x

10.1038/nrc1586

10.1073/pnas.96.5.2233

Juprelle‐Soret M, 1988, Subcellular localization of transglutaminase. Effect of collagen, Biochem J, 50, 421, 10.1042/bj2500421

10.1084/jem.20021378

10.1016/S1074-7613(02)00480-6

Pietras K, 2001, Inhibition of platelet‐derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors, Cancer Res, 1, 2929

10.1016/S1074-7613(03)00113-4

10.1084/jem.20050463

10.1046/j.1440-1711.2002.01115.x